A Randomized Case-Controlled Study of Recombinant Human Granulocyte Colony Stimulating Factor for the Treatment of Sepsis in Preterm Neutropenic Infants

Stoll, 2002, Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network, Pediatrics, 110, 285, 10.1542/peds.110.2.285 Stoll, 2004, Neurodevelopmental and growth impairment among extremely low-birthweight infants with neonatal infection, JAMA, 292, 2357, 10.1001/jama.292.19.2357 Adams-Chapman, 2012, Long-term impact of infection on the preterm neonate, Semin Perinatol, 36, 462, 10.1053/j.semperi.2012.06.009 Lahra, 2009, Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13-year hospital cohort study, Pediatrics, 123, 1314, 10.1542/peds.2008-0656 Siegel, 1981, Sepsis neonatorum, N Engl J Med, 304, 642, 10.1056/NEJM198103123041105 La Gamma, 1983, Neonatal infections. An important determinant of late NICU mortality in infants less than 1000 g at birth, Am J Dis Child, 137, 838, 10.1001/archpedi.1983.02140350016005 Banerjea, 2002, The current role of colony-stimulating factors in prevention and treatment of neonatal sepsis, Semin Neonatol, 7, 335, 10.1016/S1084-2756(02)90116-8 Ballow, 1986, Development of the immune system in very low birth weight (less than 1500g) premature infants: concentration of plasma immunoglobulins and patterns of infections, Pediatr Res, 20, 899, 10.1203/00006450-198609000-00019 Hill, 1987, Biochemical, structural, and functional abnormalities of polymorphonuclear leukocytes in the neonate, Pediatr Res, 22, 375, 10.1203/00006450-198710000-00001 Gessler, 1996, Neutrophil respiratory burst in term and preterm neonates without signs of infection and in those with increased levels of C-reactive protein, Pediatr Res, 39, 843, 10.1203/00006450-199605000-00017 Rodwell, 1993, Hematologic scoring system in early diagnosis of sepsis in neutropenic newborns, Pediatr Infect Dis J, 12, 372, 10.1097/00006454-199305000-00004 La Gamma, 2002, What is the rationale for the use of granulocyte and granulocyte-macrophage colony-stimulating factors in the neonatal intensive care unit?, Acta Paediatr Suppl, 91, 109, 10.1111/j.1651-2227.2002.tb02914.x Lanzkowski, 2010, Disorders of white blood cells, 214 Bektas, 1990, Decreased adherence, chemotaxis and phagocytic activities of neutrophils from preterm neonates, Acta Paediatr Scand, 79, 1031, 10.1111/j.1651-2227.1990.tb11379.x Speer, 1998, Neutrophil function in newborn infants, 1954 Engle, 1983, Neonatal white blood cell disorders, Semin Perinatol, 7, 184 Iguchi, 1991, Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats, Exp Hematol, 19, 352 Cairo, 1990, Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B streptococcal sepsis, Blood, 76, 1788, 10.1182/blood.V76.9.1788.1788 Gahr, 1985, Polymorphonuclear leukocyte function in term and preterm newborn infants, Biol Neonate, 48, 15, 10.1159/000242147 Russell, 1995, Granulocyte colony stimulating factor treatment for neonatal neutropenia, Arch Dis Child Fetal Neonatal Ed, 72, 53, 10.1136/fn.72.1.F53 Drossou-Agakidou, 1998, Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial, Eur J Pediatr, 157, 583, 10.1007/s004310050884 Carr, 2003, G-CSF and GM-CSF for treating or preventing neonatal infections, Cochrane Database Syst Rev, 3, CD003066 Weiss, 2003, Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission, Intensive Care Med, 29, 904, 10.1007/s00134-003-1734-y Bilgin, 2001, A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia, Pediatrics, 107, 36, 10.1542/peds.107.1.36 Ahmad, 2002, Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants, Pediatr Infect Dis J, 21, 1061, 10.1097/00006454-200211000-00017 Gillan, 1994, A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia, Blood, 84, 1427, 10.1182/blood.V84.5.1427.1427 Schibler, 1998, A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis, Pediatrics, 102, 6, 10.1542/peds.102.1.6 Kocherlakota, 1997, Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia, Pediatrics, 100, E6, 10.1542/peds.100.1.e6